ArticleApplied health economics and health policy2025

Cost-Effectiveness Analysis of Evolocumab or Inclisiran in Combination with Statins Versus Statin Monotherapy Among Patients with ASCVD in China.

Pengpeng Wang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.